lg 100268 has been researched along with Hepatocellular Carcinoma in 3 studies
LG 100268: a retinoid X receptor (RXR) selective compound; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vu-Dac, N | 1 |
| Schoonjans, K | 1 |
| Kosykh, V | 1 |
| Dallongeville, J | 1 |
| Heyman, RA | 1 |
| Staels, B | 1 |
| Auwerx, J | 1 |
| Schneider Aguirre, R | 1 |
| Karpen, SJ | 1 |
| Laffitte, BA | 1 |
| Repa, JJ | 1 |
| Joseph, SB | 1 |
| Wilpitz, DC | 1 |
| Kast, HR | 1 |
| Mangelsdorf, DJ | 1 |
| Tontonoz, P | 1 |
3 other studies available for lg 100268 and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor.
Topics: Apolipoprotein A-II; Apolipoproteins E; Base Sequence; Benzoates; Bexarotene; Carcinoma, Hepatocellu | 1996 |
Inflammatory mediators increase SUMOylation of retinoid X receptor α in a c-Jun N-terminal kinase-dependent manner in human hepatocellular carcinoma cells.
Topics: Alitretinoin; Carcinoma, Hepatocellular; Cell Line, Tumor; Hepatocytes; Humans; Inflammation Mediato | 2013 |
LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.
Topics: 3T3 Cells; Adipocytes; Animals; Anticholesteremic Agents; Apolipoproteins E; Arteriosclerosis; ATP B | 2001 |